• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/253

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

253 Cards in this Set

  • Front
  • Back
1.What are diffuse interstitial diseases?
Diffuse interstitial diseases are a heterogeneous group of disorders characterized predominantly by diffuse and usually chronic involvement of the pulmonary connective tissue, principally the most peripheral and delicate interstitium in the alveolar walls.

The interstitium consists of the basement membrane of the endothelial and epithelial cells, collagen fibers, elastic tissue, proteoglycans, fibroblasts, a few mast cells, and occasional lymphocytes and monocytes.
2. In general, what are the clinical and pulmonary functional changes in diffuse interstitial diseases?
The clinical and pulmonary functional changes are those of restrictive rather than obstructive lung disease.

Pts have dyspnea, tachypnea, end-inspiratory crackles, and eventual cyanosis, w/o wheezing or other evidence of airway obstruction.
3. What are the classic physiologic and radiographic features of diffuse interstitial diseases?
*The classic physiologic features are reductions in carbon monoxide diffusing capacity, lung volume, and compliance.

*Chest radiographs show diffuse infiltration by small nodules, irregular lines, or ground glass shadows. Eventually, secondary pulmonary hypertension and right sided HF with cor pulmonale may result.

*The advanced stages are hard to differentiate b/c they result in scarring and gross destruction of the lung, referred to as end-stage lung or honeycomb lung.
4. What are the 5 major categories of chronic interstitial lung disease?
1. Fibrosing
2. Granulomatous
3. Eosinophilic
4. Smoking-related
5. Other
5. What is the earliest common manifestation of most of the interstitial diseases?
Alveolitis, that is, an accumulation fo inflammatory and immune effector cells w/in the alveolar walls and spaces.

The accumulation of leukocytes has two consequences: it distorts the normal alveolar structures, and it results in the release of mediators that can injure parenchymal cells and stimulate fibrosis.
6. What is the initial stimuli for alveolitis?
Some are related to the inhalation of ROS and some chemicals, which are directly toxic to endothelial cells, epithelial cells, or both.

Beyond direct toxicity, a critical event is the recruitment and activation of inflammatory and immune effector cells.

Also, alveolar macrophages release chemotactic factors for neutrophils (IL-8 and leukotriene B4).
7. So, what causes the fibrosis in the later stages of interstitial diseases?
It is thought that interactions among lymphocytes and macrophages and the release of lymphokines and monokines are responsible for the slowly progressive pulmonary fibrosis that ensues.

The alveolar macrophage, in particular, plays a central role in the development of fibrosis.
8. What is idiopathic pulmonary fibrosis?
This disorder with an unknown cause refers to a syndrome with characteristic radiologic, pathologic, and clinical features.

IPF is characterized by progressive pulmonary interstitial fibrosis resulting in hypoxemia.

The histologic pattern of fibrosis is referred to as usual interstitial pneumonia (UIP).
9. What is the pathogenesis of IPF?
IPF is caused by "repeated cycles" of acute lung injury (alveolitis) by some unidentified agent.

Wound healing at these sites gives rise to exuberant fibroblastic proliferation, giving rise to the "fibroblastic foci" that are so characteristic of IPF.

Mediators of wound healing such as TGF-beta are expressed at these sites.
10. What mediators are active in IPF lesions?
May be modified by TH2 inflammatory response. Thus, eosinophils, mast cells, and IL-4 and IL-131 are found in the lesions.

Also, there is an abnormal activation of the Wnt-β-catenin signaling pathway withing the mesenchymal cells of the IPF lesions.
11. What is the morphology of IPF?

1/2
Grossly, the pleural surfaces of the lung are cobblestoned owing to the retraction of scars along the interlobular septa. The cut surface shows fibrosis (firm, rubbery white areas) of the lung parenchyma with lower lobe predominance and a distinctive distribution the subpleural regions and along the interlobular setpa.

***Microscopically, the hallmark of the UIP is patchy interstitial fibrosis, which varies in intensity and with time.
12. What is the morphology of IPF?

2/2
The earliest lesions contain exhuberent fibroblastic proliferation and appear as fibroblastic foci. W/time these areas become more collagenous and less cellular. Quite typical is the coexistence of both early and late lesions.

The dense fibrosis causes collapse of alveolar walls and formation of cystic spaces lined by hyperplastic type II pneumocytes or bronchiolar epithelium (honeycomb fibrosis).
13. What is the clinical course of IPF?
IPF begins insidiously, with gradually increasing DOE and dry cough. Most pts are 40-70 years old at the time of presentation.

Hypoxemia, cyanosis, and clubbing occur late in the course. Most pts have a gradual deterioration of their pulmonary status despite medical treatment.

The mean survival is 3 years or less. Lung transplantation is the only definitive therapy available.
14. What is nonspecific interstitial pneumonia (NSIP)?
NSIP is a diffuse interstitial lung disease of unknown etiology whose lung biopsies fail to show diagnostic features of any of the other well-characterized interstitial diseases. NSIP is divided into cellular and fibrosing patterns.

Pts present with dyspnea and cough of several mos duration. They are typically between 46-55 y/o.

*These pts have a much better prognosis than do those with UIP.
15. What is the morphology of NSIP?
The cellular pattern consists primarily of mild to moderate chronic interstitial inflammation, containing lymphocytes and a few plasma cells, in a uniform or patchy distribution.

The fibrosing pattern consists of diffuse or patchy, interstitial fibrosis w/o the temporal heterogeneity that is characteristic of UIP.

Fibroblastic foci are absent, suggesting that NSIP is not caused by alveolitis.

Those having the cellular pattern somewhat younger and they also have a better outcome than those with the fibrosing pattern or UIP.
16. What is cryptogenic organizing pneumonia (COP)?
COP is synonymous w/the term "bronchiolitis obliterans organizing pneunomia".

Pts present w/cough and dyspnea and have subpleural or peribronchial patchy areas of airspace consolidation radiographically. Some pts recover spontaneously but most need treatment with oral steroids for 6 mos or longer for complete recovery.
17. What are the histologic characteristics of COP?
***Histologically, COP is characterized by the presence of polypoid plugs of loose organizing CT w/in alveolar ducts, alveoli, and often bronchioles.

The CT is all of the same age, and the underlying lung architecture is normal.

There is no interstitial fibrosis or honeycomb lung.
18. What is COP with intra-alveolar fibrosis?
COP with intra-alveolar fibrosis can be seen as a response to infections or inflammatory injury of the lungs. These include viral and bacterial pneumonia, inhaled toxins, drugs, collagen vasscular disease, and G vs. H disease in bone marrow transplant recipients.

The prognosis is the same for these pts as that for the underlying disorder.
19. What is the pulmonary involvement in collagen vascular diseases?
Many collagen vascular disease, (e.g., SLE, RA, and scleroderma) can involve the lung.

Patterns include NSIP, UIP, vascular sclerosis, organizing pneumonia, and bronchiolitis.

NSIP pattern occurs classically in scleroderma.

Pulmonary involvement in these disease is usually associated with a poor prognosis.
20. What are the 4 forms of pulmonary involvement in RA?
1. Chronic pleuritis, w/or w/o effusion
2. Diffuse interstitial pneumonia and fibrosis
3. Intrapulmonary rheumatoid nodules
4. Pulmonary hypertension

*30-40% of pts w/classic RA have abnormalities in lung function.
21. What are pneumoconioses?
These disorders refer to the non-neoplastic lung reaction to aerosols, including mineral dusts, organic dusts, fumes and vapors. Air particulates also play a role in their formation.
22. The development of pneumoconiosis depends on what 4 things?
1. The amt of dust retained in the lungs and airways
2. The size, shape, and therefore buoyancy of the particles
3. Particle solubility and physiochemical reactivity
4. The possible additional effects of other irritants such as concommitant cigarette smoking
23. Are the most dangerous particles in pneumoconiosis large or small?
The most dangerous particles range from 1-5 μm in diameter b/c they may reach the terminal small airways and air sacs and settle in their linings.

Also, in general, the smaller the particles, the more likely it is to appear in the pulmonary fluids and reach toxic levels rapidly; therefore, smaller particles tend to cause acute lung injury.
24. Can larger particles cause injury?
Larger particles resist dissolution and so may persist w/in the lung parenchyma for years.

These tend to evoke fibrosing collagenous pneumoconioses, such as is characteristic of silicosis.
25. What can exacerbate the local reaction of lung injury due to asbestos?
Although tobacco smoking worsens the effects of all inhaled mineral dusts, the effects of asbestos are particularly magnified by smoking.
26. What is coal worker's pneumoconiosis?
These symptoms can range from:
(1) Asymptomatic anthracosis to (2) simple CWP with little to no pulmonary dysfunction to (3) complicated CWP, or progressive massive fibrosis, in which lung function is compromised.

Contaminating silica in the coal dust can favor progressive disease. in most cases, carbon dust itself is the major culprit, and studies have shown that complicated lesions contain considerably more dust than simple lesions do.
27. What is anthracosis?

What is the morphology of anthracosis?
Anthracosis is the most innocuous coal-induced pulmonary lesion in coal miners and is commonly seen in all urban dwellers and tobacco smokers. Inhaled carbon pigment is engulfed by alveolar or interstitial macrophages, which ten accumulate in teh CT along the lymphatics, including the pleural lymphatics, or in organized lymphoid tissue along the bronchi or in the lung hilus.

At autopsy, linear streaks and aggregates of anthracotic pigment readily identify pulmonary lymphatics and mark the pulmonary lymph nodes.
28. What is the morphology of simple CWP?
Simple CWP is characterized by coal macules (1-2 mm in diameter) and the somewhat large coal nodules.

The coal macules consist of carbon-laden macrophages; the nodule also contains small amts of a delicate network of collagen fibers.

These lesions can be scattered throughout the lung, but the upper lobes and upper zones of the lower lobes are more heavily involved. They are located primarily adjacent to respiratory bronchioles, the site of initial dust accumulation. In time it can lead to centrilobular emphysema.
29. What is the morphology of complicated CWP?
Complicated CWP occurs on a background of simple CWP and generally requires many years to develop. It is characterized by intensely blackened scars larger than 2 cm, sometimes up to 10 cm in greatest diameter.

They are usually multiple. Microscopically, the lesions consist of dense collagen and pigment. The center of the lesion is often necrotic, resulting most likely from local ischemia.
30. What is the clinical course of CWP?
CWP is usually a benign disease that causes little decrement in lung function. Even mild forms of complicated CWP fail to demonstrate abnormalities of lung function. In a minority of cases (fewer than 10%), complicated CWP develops, leading to increasing pulmonary dysfunction, pulmonary hypertension, and cor pulmonale.

Once that develops, it may become progressive even if further exposure to dust is prevented.
31. What is silicosis?
Silicosis is a lung disease caused by inhalation of crystalline silicon dioxide. Currently, the most preevent chronic occupational disease in the world, silicosis usually presents after decades of exposure as slowly progressing, nodular, fibrosing pneumoconiosis.
32. What is the pathogenesis of silicosis?
Silica occurs in both crystalline and amorphous forms, but crystalline forms are much more fibrogenic. Of these, quartz is most commonly implicated.

After inhalation, the particles interact w/epithelial cell and macrophages. Although lung macrophages that ingest the silica particles may ultimately succumb to its toxic effects, silica causes activation and release of mediators by viable macrophages. These mediators include IL-1, TNF, fibronectin, lipid mediators, ROS, and fribrogenic cytokines.
33. Interesting note about quartz...
It has been noted that when mixed with other minerals, quartz has a reduced fibrogenic effect. This is important b/c quartz in the workplace is rarely pure.
34. What is the morphology of silicosis?
Silicosis is characterized grossly in its early stages by tiny, barely palpable, discrete pale to blackened (if coal dust is also present) nodules in the upper zones of the lungs. As the disease progresses, these nodules may coalesce into hard, collagenous scars. Some nodules may undergo central softening and cavitation. This change may be due to superimposed tuberculosis or ischemia.

Fibrotic lesions may also occur in the hilar lymph nodes and pleura. ****Sometimes, thin sheets of calcification occur in the lymph nodes and are seen radiographically as eggshell calcifications.

Histologically, the nodular lesions consist of concentric layers of hyalinized collagen surrounded by a dense capsule of more condensed collagen.

***Examination of the nodules by polarized microscopy reveals the birefringent silica particles.
35. What is the clinical course of silicosis?
The disease is usually detected when routine chest xray is performed on an asymptomatic worker. The radiographs typically show a fine nodularity in the upper zones of the lung, but pulmonary functions are either normal or only moderately affected.

Most pts do not develop dyspnea until later in the course. At this time, the disease may be progressive even if the pt is no longer exposed.
36. Silicosis is associated with increased susceptibility to...?
Tuberculosis. It is postulated tha tilicosis results in a depression of cell-mediated immunity, and crystalline silica may inhibit the ability of pulmonary macrophages to kill phagocytosed mycobacteria.

Nodules of silicotuberculosis often display a central zone of caseation.
37. Occupational exposure to asbestos is linked to what 6 things...?
1. Localized fibrous plaques or rarely diffuse pleural fibrosis
2. Pleural effusions
3. Parenchymal interstitial fibrosis (asbestosis)
4. Lung CAs
5. Mesotheliomas
6. Laryngeal and perhaps other extrapulmonary neoplasms, including colon CA
38. What are the two distinct geometric forms of asbestos?
Serpentine (curly and flexible fibers) and amphibole (straight, stiff, and brittle fibers.

The serpentine form accounts for most of the asbestos used in industry.

However, it is the amphibole stiff fibers that are delivered deeper into the lungs, where they can penetrate epithelial cells and cause fibrogenic disease.

*Thus, only amphibole exposure correlates with mesothelioma.
39. How is asbestos a tumor initiator/promoter?
Some of the oncogenic effects of asbestos are mediated by ROS generated by asbestos fibers, which preferentially localize in the distal lung, close to the mesothelial layers.

In addition, adsorption of carcinogens in tobacco smoke onto asbestos fibers may well be important in the synergy between tobacco smoking and the development of lung CA.
40. What is the disease like in asbestosis?
Chronic deposition of fibers and persistent release of mediators eventually lead to generalized interstitial pulmonary inflammation and *interstitial fibrosis*
41.What is the morphology of the diffuse pulmonary interstitial fibrosis in asbestosis?
Indistinguishable from other causes, except for the presence of asbestos bodies.

Asbestos bodies appear as golden brown, fusiform or beaded rods w/a translucent center and consist of asbestos fibers coated with an iron containing proteinaceous material.

They arise when macrophages attempt to phagocytose asbestos fibers; the iron is presumably derived from phagocyte ferritin. Other inorganic particulates may become coated with similar iron protein complexes and are called ferruginous bodies.
42. Where does asbestosis begin?
In contrast to CWP and silicosis, asbestosis begins in the lower lobes and subpleurally.

The middle and upper lobes of the lungs become affected as fibrosis progresses. The scarring may trap and narrow pulmonary arteries and arterioles causing pulmonary hypertension and cor pulmonale.
43. What are pleural plaques?
Pleural plaques are the most common manifestation of asbestos exposure. They are well-circumscribed plaques of dense collagen, often containing calcium. They develop most frequently on the anterior and posterolateral aspects of the parietal pleura and over the domes of the diaphragm.

They do not contain asbestos bodies; however, only rarely do they occur in individuals w/o asbestos exposure.
44. What is the clinical course of asbestosis?
Dyspnea is usually the first manifestation; at first, it is provoked by exertion, but later it is present even at rest. The dyspnea is usually accompanied by a cough associated w/sputum.

These manifestations rarely appear fewer than 10 years after first exposure and are more common after 20 years or more. The disease may remain static or progress to respiratory failure, cor pulmonale, and death.

With advancement of pneumoconiosis, a honeycomb pattern develops. Asbestosis complicated by lung or pleural CA is associated with a particularly grim prognosis.
45. What are drug-induced lung disease?
Drugs can cause both acute and chronic alterations in respiratory structure and function, including bronchospasm, pulmonary edema, diffuse alveolar damage, organizing pneumonia, interstitial fibrosis, bronchiolitis obliterans, and esoinophilic pneumonia.

For example, cytotoxic drugs used in CA treatment, (e.g., bleomycin) cause pulmonary damage and fibrosis as a result of direct toxicity of the drug and by stimulating the influx of inflammatory cells into the alveoli.

Amiodarone is preferentially concentrated in the lung and causes significant pneumonitis in 5-15% of pts receiving it.
46. What about acute radiation pneumonitis?
After clinical fractionated irradiation, acute radiation pneumonitis occurs in 10-20% of pts, 1-6 mos after therapy, manifested by fever, dyspnea out of proportion to the volume of lung irradiated, pleural effusion, and radiologic infiltrates that usually correspond to an area of previous radiation.

With steroid therapy, these symptoms may resolve completely in some pts without long-term effects.
47. What about chronic radiation pneumonitis?
There is increasing evidence that irradiation of the lungs initially causes a lymphocytic alveolitis or hypersentivity pneumonitis that can lead to pulmonary fibrosis (chronic radiation pneumonitis). The latter is a consequence of repair, which is initiated by direct tissue injury to endothelial and epithelial cells w/in the radiation portal.

Morphologic changes are those of DAD, including severe atypia of hyperplastic type II cells and fibroblasts. Form cells and epithelial cell atypia within vessel walls are also characteristic of radiation damage.
48. What is sarcoidosis?
Sarcoidosis is a systemic disease of unknown cause characterized by noncaseating granulomas in many tissues and organs. It presents in many clinical patterns, but bilateral hilar lymphadenopathy or lung involvement is visible on chest xrays in 90% of cases. Eye and skin lesions are next in frequency.

The prevalence of sarcoidosis is higher in women than in men; in the US, the rates are highest in the Southeast; they are 10x higher in blacks than in whites.
49. What are 3 local immunologic factors in the pathogenesis of sarcoidosis?
1. Intra-alveolar and intersitital accumulation of CD4+ T cells; antigen-driven proliferation
2. Increased levels of TH1 cytokines such as IL-2 and IFN-gamma, resulting in T-cell expansion and macrophage activation
3. Increased levels of several cytokines in the local environment (IL-8, TNF, macrophage inflammatory protein 1-alpha)
50. What are 2 systemic immunologic factors in the pathogenesis of sarcoidosis?
1. Anergy to common skin test antigens such as Candida or PPD
2. Polyclonal hypergammaglobulinemia, another manifestation of helper-T cell dysregulation
51. What are the genetic influences in sarcoidosis?
1. Familial and racial clustering of cases
2. Association with certain HLA genotypes (e.g., class I HLA-A1 and HLA-B8)
52. What are the environmental factors associated with sarcoidosis?
Several putative microbes have been proposed as the inciitng agent for sarcoidosis (e.g., mycobacteria, Propionibacterium acnes, and Rickettsia species).

*To date, there is no unequivocal evidence to suggest that sarcoidosis is caused by an infectious agent.
53. What are the histological characteristics of sarcoidosis?
Histologically, all involved tissues show the classic noncaseating granulomas, each composed of an aggregate of tightly clustered epithelioid cells, often with Langhans or foreign body type giant cells. Central necrosis is unusual.

With chronicity the granulomas may become enclosed w/in fibrous rims or may eventually be replaced by hyaline fibrous scares.
54. What are two microscopic features often present in the granulomas of sarcoidosis?
1. Laminated concretions composed of calcium and proteins known as Schaumann bodies

2. Stellate inclusions known as asteroid bodies enclosed within giant cells found in approximately 60% of the granulomas.

*Although characteristic, these microscopic features are not pathognomonic of sarcoidosis b/c asteroid and Schaumann bodies maybe encountered in tuberculosis.
55. What is the morphology of the lungs in sarcoidosis?
The lungs are common sites of involvement. Macroscopically, there is usually no demonstrable alteration, although at times, the coalescence of granulomas may produce small nodules that are palpable or visible as 1-2 cm noncaseating, noncavitated consolidations.

Histologically, the lesions are distributed primarily along the lymphatics, around bronchi and blood vessels, although alveolar lesions are also seen.

*A CD4/CD8 ratio > 2.5 and the CD3/CD4 ratio < 0.31 is bronchoalveolar lavage lymphocytes is commonly seen in sarcoidosis.
56. What is the morphology of the lymph nodes in sarcoidosis?
Lymph nodes are involved in almost all cases *specifically the hilar and mediastinal nodes*, but any other node in the body may be involved.

Nodes are characteristically enlarged, discrete, and sometimes calcified. The tonsils are affected in about 25-33% of cases.
57. How are the spleen and liver affected in sarcoidosis?
The spleen is affected microscopically in about 75% of cases, but it is enlarged in only one fifth. On occasion, granulomas may coalesce to form small nodules that are barely visible macroscopically. The capsule is not involved.

The liver is affected slightly less often than the spleen. It may also be moderately enlarged and may contain scattered granulomas, more in portal triads than in the lobular parenchyma.
58. What about the bone marrow and sarcoidosis?
The bone marrow is an additional favored site of localization. Roentgenographic changes can be identified in about one firth of cases of systemic involvement.

The radiologically visible bone lesions have a particular tendency to involve phalangeal bones of the hands and feet, creating small circumscribed areas of bone resorption within the marrow cavity and a diffuse reticulated pattern throughout the cavity, with widening of the bony shafts or new bone formation on the outer surfaces.
59. What are the skin lesions in sarcoidosis?
Sin lesions are encountered in one third to one half of cases. Sarcoidosis of the skin assumes a variety of macroscopic appearances (e.g., discrete subcutaneous nodules; focal, slightly elevated, erythematous plaques; or flat lesions that are slightly reddened and scaling and resemble those of SLE).

Lesions may also appear on the mucous membranes of the oral cavity, larynx, and upper respiratory tract.
60. What are the ocular involvements like in sarcoidosis?
The eye, its associated glands, and the salivary glands are involved in one fifth to half of cases.

The ocular involvement takes the form of iritis or iridocyclitis, either bilaterally or unilaterally. Consequently, corneal opacities, glaucoma, and total loss of vision may occur. These ocular lesions are frequently accompanied by inflammation of the lacrimal glands, with suppression of lacrimation.
61. What is Mikulicz syndrome?
Bilateral sarcoidosis of the parotid, submaxillary, and sublingual glands completes the combined uveoparotid involvement designated as Mikulicz syndrome.
62. What are the muscle involvements in sarcoidosis?
Muscle involvement is often undiagnosed, since is may be asymptomatic. Symptoms of muscle weakness, aches, tenderness, and fatigue should prompt consideration of occult sarcoid myositis. Sarcoid noncaseating granulomas can be found in muscle biopsies.

Sarcoid granulomas occasionally occur in the heart, kidneys, CNS, and endocrine glands, particularity in the pituitary, as well as in other body tissues.
63. What is the clinical course of sarcoidosis?
May follow an unpredictable course:
-It can be slowly progressive
-It may pursue a remitting and resolving course (w/ or w/o steroid therapy)
-It can spontaneously resolve
-In 65-70% of pts, there are no or only minimal residual manifestations; 20% have permanent lung or ocular dysfunction; and 10% of pts die, primarily from progressive pulmonary fibrosis
64. What is hypersensitivity pneumonitis?
This immunologically mediated disorder is caused by intense, often prolonged exposure to inhaled organic dusts and related occupational antigens.

Affected individuals have an abnormal sensitivity or heightened reactivity to the antigen, which in contrast to asthma, involves primarily the alveoli.

***It is important to recognize these diseases early in their course b/c progression to serious chronic fibrotic lung disease can be prevented by removal of the environmental agent.
65. What causes the hypersensitivity?
It results from the inhalation of organic dust containing antigens made up of spores of thermophilic bacteria, true fungi, animal proteins, or bacterial products. Uses type III and type IV hypersensitivity reactions.

Examples:
1. Farmer's lung from exposure to dusts from hay that permits actinomycetes sports
2. Pigeon breeder's lung
3. Humidifier or A/C lung is caused by thermophilic bacteria in heated water reservoirs.
66. What are 5 lines of evidence supporting that hypersensitivity pneumonitis is an immunologically mediated disease?
1. Bronchoalveolar lavage specimens obtained during the acute phase show increased levels of proinflammatory chemokines such as MIP-1alpha and IL-8.
2. Bronchoalveolar lavage specimens also consistently demonstrate increased numbers of T lymphs of both CD4+ and CD8+ phenotypes.
3. Most pts have specific antibodies in their serum, a feature suggestive of type II (immune complex) hypersensitivity
4. Complement and immunoglobulins have been demonstrated w/in vessel walls, also indicating type III hypersensitivity.
5. The presence of noncaseating granulomas in 2/3's of pts suggests the development of a T cell-mediated (type IV) delayed-type hypersensitivity against the implicated antigens.
67. What is the morphology of hypersensitivity pneumonitis?
Histologic changes in subacute and chronic forms are characteristically centered on bronchioles.

They include (1) interstitial pneumonitis consisting primarily of lymphocytes, plasma cells, and macrophages; (2) noncaseating granulomas in 2/3rds of pts; and (3) interstitial fibrosis and obliterative bronchiolitis (in later stages).
68. What are the clinical features of hypersensitivity pneumonitis?
The clinical manifestations are varied. Acute attacks, which follow inhalation of antigenic dust in sensitized pts, consist of recurring episodes of fever, dyspnea, cough, and leukocytosis. Diffuse and nodular infiltrates appear in the chest Xray and pulmonary function tests show an acute restrictive disorder.

Symptoms usually appear 4-6 hrs after exposure. If exposure is continuous and protracted, a chronic form of the disease supervenes that no long features the acute exacerbations on antigen re-exposure. Instead, there are signs of progressive respiratory failure, dyspnea, and cyanosis and a decrease in total lung capacity and compliance.
69. What is pulmonary esoinophila?
Pulmonary eosinophilia refers to diverse clinicopathologic conditions characterized by eosinophil infiltrates in pulmonary interstitial or alveolar spaces.
70. What are the 5 types of pulmonary eosinophilia?
1. Acute eosinophilic pneumonia w/respiratory failure
2. Simple pulmonary esoinophilia or Loffler sydnrome
3. Tropical esoinophilia, caused by infection with microfilariae
4. Secondary eosinophilia
5. So called idiopathic chronic eosinophilic pneumonia
71. What is acute eosinophilic pneumonia w/respiratory failure?
This is an acute illness of unknown cause. It has a rapid onset w/fever, dyspnea, and hypoxemic respiratory failure.

The chest X-ray shows diffuse infiltrates and bronchoalveolar lavage fluid contains more than 25% eosinophils.

*There is a prompt response to corticosteroids.
72. What is simple pulmonary eosinophilia or Loffler syndrome?
Simple pulmonary eosinophilia is characterized by transient pulmonary lesions, eosinophilia in the blood, and a benign clinical course. Roentgenograms are often quite striking, w/shadows of varying size and shape in any of the lobes, suggesting irregular intrapulmonary densities.

They alveolar septa are thickened by an infiltrate composed of eosinophils and occasional interspersed giant cells, but there is no vasculitits, fibrosis, or necrosis. In some cases, the eosinophils are found in a background of DAD.
73. What is chronic eosinophilic pneumonia?
Chronic eosinophilic pneumonia is characterized by focal areas of cellular consolidation of the lung substance distributed chiefly in the periphery of the lung fields.

Prominent in these lesions are heavy aggregates of lymphocytes and eosinophils w/in both the septal walls and the alveolar spaces.

These pts have high fever, night sweats, and dyspnea, all of which respond to corticosteroid therapy.

Chronic eosinophilic pneumonia is Dx when other causes of chronic pulmonary eosinophilia are excluded.
74. What is desquamative interstitial pneumonia (DIP)?

What is the morphology?
***Desquamative interstitial pneumonia is characterized by large intra-alveolar collections of macrophages with abundant cytoplasm containing dusty brown pigment (smoker's macrophages) in the airspaces.***

Some of the macrophages contain lammellar bodies (surfactant) w/in phagocytic vacuoles, presumably derived from necrotic type II pneumocytes.

The septa are lined by plump cuboidal pneumocytes. Interstitial fibrosis, when present, is mild. Emphysema is often present.
75. What is the clinical course of DIP?
DIP usually presents in the 4th or 5th decade of life, and it is more common in men than in women by a ratio of 2:1.

Virtually all pts are cigarette smokers. Presenting symptoms include an insidious onset of dyspnea and dry cough over weeks or months, often associated w/clubbing of digits. Pulmonary functions usually show a mild restrictive abnormality w/a moderate reduction of the diffusing capacity of carbon dioxide.

Pts with DIP typically have a good prognosis with excellent response to steroid therapy and cessation of smoking.
76. What is respiratory bronchiolitis-associated interstitial lung disease?
Respiratory bronchiolitis is a common histologic lesion found in cigarette smokers. It is characterized by the presence of pigmented intraluminal macrophages within first and second order respiratory bronchioles.

In its mildest form , it is seen most often as an incidental histologic finding in the lungs of smokers or ex-smokers.
77. What is the morphology of respiratory bronchiolitis-associated interstitial lung disease?
The changes are patchy at low magnification and have a bronchiolocentric distribution. ***Respiratory bronchioles, alveolar ducts, and peribronchiolar spaces containing aggregates of dusty brown macropahges (smoker's macrophages) similar to those seen in DIP.***

There is a patchy submucosal and peribronchiolar infiltrate of lymphocytes and histiocytes. Mild peribronchiolar fibrosis is also seen, which expands contiguous alveolar septa. Centrilobular emphysema is common but not severe.
78. What are the clinical features of respiratory bronchiolitis-associated interstitial lung disease?
Symptoms are usually mild, consisting of gradual onset of dyspnea and cough in pts who are typically current smokers in the 4th or 5th decade of life with average exposures of over 30 pack years of cigarette smoking.

There is a 2:1 male predominance. Cessation of smoking usually results in improvement.
79. What is pulmonary alveolar proteinosis (PAP)?
PAP is a rare disease that is characterized radiologically by bilateral patchy asymmetric pulmonary opacification and histologically by ***accumulation of accelular surfactant in the intra-alveolar and bronchiolar spaces.***

There are three classes of this disease: acquired, congenital, and secondary PAP.
80. What is acquired PAP?
Acquired PAP accounts for 90% of cases.

Autoimmune anti-GM-CSF antibodies may be pathogenic. These antibodies ultimately lead to impaired surfactant clearance by pulmonary macrophages.

Thus, acquired PAP can be considered an autoimmune disorder.
81. What is congenital PAP?
Congenital PAP is a rare cause of immediate-onset neonatal respiratory distress. To date, mutation in three genes have been found for congenital PAP: sufactant protein B (SP-B), GM-CSF, and GM receptor beta chain.

SP-B deficiency is transmitted in an autosomal recessive manner and is most often caused by homozygosity for a frameshift mutation in the SP-B gene. This leads to an unstable SP-B mRNA, reduced or absent SP-B, secondary disturbances of SP-C, and intra-alveolar accumulation of SP-A and SP-C.
82. What is secondary PAP?
Secondary PAP is uncommon. The underlying causes include lysinuric protein intolerance, acute silicosis, and other inhalational syndrome, immunodeficiency disorders, malignancies, and hematopoietic disorders.
83. What is the morphology of PAP?
The disease is characterized by a peculiar homogeneous, granular precipitate within the alveoli, causing focal-to-confluent consolidation of large areas of the lungs w/minimal inflammatory reaction. On section, turbid fluid exudes from these areas. As a consequence, there is a marked increase in the size and weight of the lung.

The alveolar precipitate is PAS positive and also contains cholesterol clefts. Immunohistochemical stains show the presence of surfactant proteins A and C in congenital SP-B deficiency and all three proteins in the acquired form.
84. What are the clinical features of PAP?
Adult pts for the most part, present with nonspecific respiratory difficultly of insidious onset, cough, and abundant sputum that often contains chunks of gelatinous material.

Some pts have symptoms lasting for years, often with febrile illnesses. These pts are at risk for developing secondary infections with a variety of organisms. Progressive dyspnea, cyanosis, and respiratory insufficiency may occur, but some pts tend to have a benign course.

Whole-lung lavage remains the standard of care.
85. What about congenital PAP?
Congenital PAP is a fatal respiratory disorder that is usually apparent in the newborn. Typically, the infant is full term and rapidly develops progressive respiratory distress shortly after birth. W/o lung transplantation, death ensues between 3-6 months of age.
86. Blood clots that occlude the large pulmonary arteries are almost always from where?
Blood clots that occlude the large pulmonary arteries are almost always emoblic in origin.

The usual source of pulmonary emboli is thrombi in the deep veins of the legs in more than 95% of cases.
87. What type of people are predisposed to having pulmonary embolisms?
Pulmonary embolism is a complication principally in pts who are already suffering from some underlying disorder, such as cardiac disease or CA, or who are immobilized for several days or weeks, those w/hip fracture being at high risk.

Hypercoagulable states, either primary (e.g. Factor 5 leiden, prothrombin 20210 A, hyperhomocyteinemia, and antiphospholipid syndrome) or secondary (e.g., obesity, recent surgery, CA, oral contraceptive use, pregnancy) are frequent risk factors.

Also indwelling central venous lines can be a nidus for right atrial thrombus, which can be a source of pulmonary embolism.
88. The pathophysiologic response and clinical significance of pulmonary embolism depends on...?
Depends on the extent to which the pulmonary artery blood flow is obstructed, the size of the occluded vessel(s), the number of emboli, the overall status of the cardiovascular system, and the release of vasoactive factors such as thromboxane A2 from platelets that accumulate at the site of thrombus.
89. Emboli result in what 2 main pathophysiologic consequences?
1. Respiratory compromise owing to the nonperfused, although ventilated, segment.

2. Hemodynamic compromise owing to increased resistance to pulmonary blood flow engendered by the embolic obstruction. This leads to pulmonary hypertension and can cause acute right-sided heart failure.
90. What are the morphologic consequences of embolic occlusion of the pulmonary arteries?
This depends on the size of the embolic mass and the general state of the circulation. Large emboli may impact in the main pulmonary artery or its major branches or lodge at the bifurcation as a saddle embolus. Sudden death often ensues, owing largely to the blockage of blood flow thru the lungs. Death may also be caused by acute cor pulmonale.

Smaller emboli can travel out into the more peripheral vessels, where they may cause infarction.
91. When are infarctions in the lung not a serous problem?

What occurs instead?
In pts with adequate cardiovascular function, the bronchial arterial supply can often sustain the lung parenchyma despite obstruction to the pulmonary arterial system.

Under these circumstances, hemorrhages may occur, but there is no infarction of the underlying lung parenchyma.

Only about 10% of emboli actually cause infarction. Although the underlying pulmonary architecture may be obscured by the suffusion of blood, ***hemorrhages are distinguished by the preservation of the pulmonary alveolar architecture***; in such cases, resorption of the blood permits reconstitution of the preexisting architecture.
92. So, when do pulmonary embolisms cause infarction?
PEs usually causes infarction only when the circulation is already inadequate, as in pts with heart or lung disease.

About 3/4 of all infarcts affect the lower lobes, and in more than half, multiple lesions occur. They vary in size from lesions that are barely visible to the naked eye to massive involvement of large parts of an entire lobe.

Characteristically, they extend to the periphery of the lung substances as a wedge with the apex pointing toward the hilus of the lung. In many cases, an occluded vessel can be identified near the apex of the infarct.
93. What is the morphology of a pulmonary infarct?
The pulmonary infarct is classically hemorrhagic and appears as a raised, red-blue area in the early stages. Often, the apposed pleural surface is covered by a fibrinous exudate.

The red cells begin to lyse w/in 48 hours, and the infarct becomes paler and eventually red brown as hemosiderin is produced. With the passage of time, fibrous replacement begins at the margins as a gray-white peripheral zone and eventually converts the infarct into a contracted scar.
94. What are the histologic features of pulmonary infarcts?
Histologically, the diagnostic feature of acute pulmonary infarction is the ischemic necrosis of the lung substance within the area of hemorrhage, affecting the alveolar walls, bronchioles, and vessels. If the infarct is caused by an infected embolus, it is modified by a more intense neutrophilic exudation and more intense inflammatory reaction.

Such lesions are referred to as septic infarcts, and some convert to abscesses.
95. What is one of the few causes of virtually instantaneous death?
A large pulmonary embolism.

During CPR resuscitation in such instances, the pt frequently is said to have electromechanical dissociation, in which the EKG has a rhythm but no pulses are palpated b/c of the massive blockage of blood in the systemic venous circulation.

If the pt survives after a sizable pulmonary embolus, however, the clinical syndrome may mimic MI, with severe chest pain, dyspnea, shock, elevation of temperature, and increased levels of serum lactic dehydrogenase.
96. What about small emboli?
Usually, however, in individuals with normal cardiovascular system small emboli induce only transient chest pain and cough or possibly pulmonary hemorrhages w/o infarction. Only in the predisposed, in whom the bronchial circulation itself is inadequate, do small emboli cause small infarcts. Such pts manifest dyspnea, tachypnea, fever, chest pain, cough, and hemoptysis.
97. How are PE's diagnosed?
The chest radiograph may disclose a pulmonary infarct, usually 12-36 hours after it has occurred, as a wedge-shaped infiltrate. Emboli can also be detected by spiral CT angiography and D-dimer testing. *Pulmonary angiography is the most definitive diagnostic technique but entails more risk to the pt.
98. What happens after the initial acute insult from a PE?
The emboli often resolve via contraction and fibrinolysis, particularly in the relatively young. Unresolved, multiple small emboli over the course of time may lead to pulmonary hypertension, pulmonary vascular sclerosis, and chronic cor pulmonale.

*Most important is the fact that a small embolus may presage a large one. In the presence of an underlying predisposing factor, pts with a pulmonary embolus have a 30% chance of developing a second embolus.
99. What is pulmonary hypertension?
Pulmonary hypertension is when the mean pulmonary pressure reaches one fourth of systemic levels.

It is most frequently secondary to structural cardiopulmonary conditions that increase pulmonary blood flow or pressure (or both), pulmonary vascular resistance, or left heart resistance to blood flow.
100. What are these structural cardiopulmonary conditions that can lead to pulmonary hypertension (4 of them)...?
1. Chronic obstructive or interstitial lung diseases
2. Antecedent congenital or acquired heart disease (mitral stenosis)
3. Recurrent thromboemboli
4. Autoimmune disorders (*systemic sclerosis*)
101. What is primary, or idiopathic, pulmonary hypertension?
Uncommonly, pulmonary hypertension is encountered in pts in whom all known causes of increased pulmonary pressure are excluded.

This condition is most commonly sporadic; only 6% of pts have the familial form with autosomal-dominant mode of inheritance. Within these families, there is incomplete penetrance, and only 10% to 20% of the family members actually develop overt disease.
102. What are the genetic causes of primary pulmonary hypertension?
Studies have revealed that primary pulmonary hypertension is caused by mutations in the bone morphogenetic protein receptor type 2 (BMPR2) signaling pathway.

BMPR2 is a cell-surface protein which binds a variety of cytokines, including TFG-beta, BMP, activin, and inhibin.
103. So, how does a mutation in BMPR2 causes primary pulmonary hypertension?
In vascular smooth muscle cells, BMPR2 signaling causes inhibition of proliferation and favors apoptosis.

Thus, in the absence of such signaling, smooth muscle proliferation may be expected.

*Inactivating germ line mutations in the BMPR2 gene are found in 50% of the familial (primary) cases of pulmonary hypertension and 26% of sporadic cases.
104. What is the pathogenesis of secondary forms of pulmonary hypertension?
In secondary forms of pulmonary hypertension, endothelial cell dysfunction is produced by the process that initiates the disorder, such as the increased shear and mechanical injury associated with left-to-right shunts or the biochemical injury produced by fibrin in thromboembolism.

Deceased elaboration of prostacyclin, decreased production of NO, and increased release of endothelin all promote pulmonary vasoconstriction. Also, decreased elaboration of prostacyclin and NO promotes platelet adhesion and activation.
105. What plants or medicines can cause pulmonary hypertension?
Ingestion of the leguminous plant Crotalaria spectabilis, which is indigenous to the tropics and used medicinally in bush tea, the appetite depressant agent, aminorex, adulterated olive oil, and Fenfen obesity drug.

It has been suggested that such substances might act thru effect on serotonin transporter expression or activity.
106. What is the morphology of the vascular lesions in pulmonary hypertension?
The presence of many organizing or recanalized thrombi favors recurrent PE as the cause, and the coexistence of diffuse pulmonary fibrosis, or severe emphysema and chronic bronchitis, points to chronic hypoxia as the initiating event.

The vessel changes can involve the entire arterial tree. In most severe cases, atheromatous deposits form in the pulmonary artery and its major branches, resembling systemic atherosclerosis.

The arterioles and small arteries are most prominently affect, with striking increases in the muscular thickness of the media (medial hypertrophy) and intimal fibrosis. These changes are present in all forms of pulmonary hypertension but are best developed int he primary form.
107. What is plexogenic pulmonary arteriopathy?
One extreme present most prominently in primary pulmonary hypertesnsion ro congenital heart disease with left-to-right shunts is plexogenic pulmonary arteriopathy.

The characteristic features include tufts of capillary formations is present, producing a network, or web, that spans the lumens of dilated thin-walled, small arteries.
108. What is the clinical course of pulmonary hypertension?
Primary pulmonary hypertension is uncommon, typically occurring in women 20-40 years old.

Clinical signs and symptoms of both primary and secondary forms become evdient only with advanced arterial disease. In the course of time, the features generally progresses to severe respiratory insufficiency, cor pulmonale, and death over several years, often superimposed with thromboembolissm and pneumonia.

Therapies include vasodilators, antithrombotic medications, and occasionally lung transplantation.
109. What are the 3 diffuse pulmonary hemorrhage syndromes?
1. Goodpasture syndrome
2. Idiopathic pulmonary hemosiderosis
3. Vasculitis-associated hemorrhage, which is found in conditions such as hypersensitivity angiitis, Wegener granulomatosis, and SLE
110. What is Goodpasture syndrome?
Goodpasture syndrome is an uncommon autoimmune disease characterized by the presence of circulating autoantibodies targeted against the noncollageneous domain of the α-3 chain of collagen IV.

The antibodies initiate an inflammatory destruction of the basement membrane in the kidney glomeruli and lung alveoli, giving rise to proliferative, usually RPGN and a necrotizing hemorrhagic interstitial pneumonitis.

Most cases occur in the teens or twenties, and in contrast to many other autoimmune diseases, there is a preponderance among men, and men that smoke.
111. What is the morphology of Goodpasture syndrome?
In the classic case, the lungs are heavy, with areas of red-brown consolidation. Histologically, there is focal necrosis of alveolar walls associated with intra-alveolar hemorrhages. Often, the alveoli contain hemosiderin-laden macrophages.

In later stages there may be fibrous thickening of the septae, hypertrophy of type II pneumoncytes, and organization of blood in alveolar spaces.

The immunofluorescence studies reveal linear deposits of Ig's along the basement membranes.
112. What are the clinical features of Goodpasture syndrome?
Most cases begin clinically with respiratory symptoms, principally hemoptysis, and radiographic evidence of focal pulmonary consolidations. Soon, manifestations of glomerulonephritis appear, leading to rapidly progressive renal failure.

The common cause of death is uremia. Plasma exchange is thought to be beneficial by removing circulating antibasement membrane antibodies as well as chemical mediators of immunologic injury.
113. What is idiopathic pulmonary hemosiderosis?
It is a rare disorder characterized by intermittent, diffuse alveolar hemorrhage. It usually presents with an insidious onset of productive cough, hemotysis, anemia, and weight loss associated with diffuse pulmonary infiltrations similar to Goodpasture syndrome. Most cases occur in children, although the disease occurs in adults as well.
114. What is the morphology of idiopathic pulmonary hemosiderosis?
The lungs are moderately increased in weight, with areas of consolidation that are usually red-brown to red.

*The cardinal histologic features are hemorrhage into the alveolar spaces, and hemosiderosis, both within the alveolar septa and in macrophages lying free within the pulmonary alveoli.

There may also be hyperplasia of type II pneumocytes and varying degrees of interstitial fibrosis.
115. What are the important features in the lungs in Wegener granulomatosis?
The diagnostically important features are *capillaritis and scattered, poorly formed granulomas* (unlike those of sarcoidosis, which are rounded and well-defined).
116. What are the five ways in which the lung clearing mechanisms can be interfered?
1. Loss or suppression of the cough reflex, as a result of coma, anesthesia, neuromuscular disorders, drugs, or chest pain.
2. Injury to the mucociliary apparatus, by either impairment of ciliary function or destruction of ciliated epithelium
3. Interference w/the phagocytic or bactericidal action of alveolar macrophages by alcohol, tobacco smoke, anoxia, or oxygen intoxication
4. Pulmonary congestion and edema
5. Accumulation of secretions in conditions such as cystic fibrosis and bronchial obstruction
117. Defects in innate immunity and humoral immunodeficiency lead to an increase in infections with...?
Pyogenic bacteria
118. Cell-mediated immune defects lead to increased infections with...?
Intracellular microbes such as mycobacteria and herpesviruses as well as with microorganisms of very low virulence, such as Pneumocystis carinii.
119. What are 3 important points to remember about pneumonia?
1. One type of pneumonia sometimes predisposes to another, especially in debilitated patients

2. Hematogenous spread from one organ to other organs can occur

3. Many patients w/chronic diseases acquire terminal pneumonias while hospitalized
120. Streptococcus pneumonia
*This is the most common cause of community acquired acute pneumonia.

The presence of gram-positive, lancet shaped diplococci within neutrophils is indicative of diagnosis, but it must be remembered that this organisms is part of the endogenous flora in 20% of adults.
121. Haemophilus influenzae
H. influenzae are pleomorphic, gram-negative, encapsulated (six serotypes - 5%) or unencapsulated (untypable - 95%) bacterial.

They cause life-threatening lower respiratory tract infections and meningitis in children and are a common cause of pneumonia in adults, especially those with COPD.
122. Which type of H. influenzae is the most frequent cause of severe invasive disease?
Used to be type B, but not the most frequent cause is from infections with nonencapsulated forms.
123.What mediates the adherence and survival of the H. influenzae?
Pili on the surface of H. influenzae mediate adherence to the respiratory epithelium.

Survival of this organism in the blood stream correlates w/the presence of the capsule, which, like that of pneumococcus, prevents opsonization by complement and phagocytosis by host cells.
124. Moraxella catarrhalis
Causes bacterial pneumonia, especially in the elderly.

It is the second most common bacterial cause of acute exacerbation of COPD.

It is also a common cause of otitis media in children.
125. S. aureus
S. aureus is an important cause of secondary bacterial pneumonia in children and healthy adults following viral respiratory illness.

Staphylococcal pneumonia is associated w/a high incidence of complications such as lung abscess and empyema.

IV drug abusers are at high risk of developing staphylococcal pneumonia in association w/endocarditis.
126. Klebsiella pneumoniae
K. pneumoniae is the most common cause of gram-negative pneumonia.

It afflicts debilitated individuals, especially chronic alcoholics.

Thick and gelatinous sputum is characteristic b/c the organism produces an abundant viscid capsular polysaccharide, which the patient may have difficulty coughing up.
127. Pseudomonas aeruginosa
Pseudomonas aeruginosa is common in cystic fibrosis patients.

It is also common in pts who are neutropenic and it has a propensity to invade blood vessels with consequent extrapulmonary spread.
128. Legionella pneumophila
L. pneumophila spreads through aerosolization; infection causes severe pneumonia in the immunocompromised patient, such as those individuals with cardiac, renal, or hematologic disease.

It is common in artificial aquatic environments.
129. Pontiac fever
Pontiac fever is a related self-limited upper respiratory tract infection caused by L. pneumophila, without pneumonic symptoms.
130. What is the morphology of bacterial pneumonia?
There are two gross patterns of anatomic distribution:

1. Bronchopneumonia
2. Lobar pneumonia

Most important from the clinical standpoint are identification of the causative agent and determination of the extent of the disease.
131. What is the morphology of bronchopneumonia?
Bronchopneumonia is marked by ***patchy exudative consolidation of lung parenchyma***; staphyloccci, pneumococci, H. influenzae, P. aeruginosa, and coliform bacteria are the most common agents.

Grossly, the lungs show dispersed, elevated, focal areas of palpable consolidation and suppuration.

Histologically, there is acute (neutrophilic) suppurative exudation filling airways and air spaces, usually around bronchi and bronchioles.

Resolution spaces of the exudate usually restores normal lung structure, but organization w/fibrous scarring can occur, or aggressive disease can produce abscesses.
132. What is the morphology of lobar pneumonia?
Lobar pneumonia involves a large portion of or an entire lobe of lung.

Most lobar pneumonias are caused by pneumococci entering the lungs via the airway.

Occasionally, they are caused by other organisms (K. pneumoniae, staphylococci, streptococci, H. influenzae).
133. What are the four stages of lobar pneumonia?
1. Congestion
-characterized by vascular engorgement, intra-alveolar fluid w/few neutrophils, and often the presence of numerous bacteria.

2. Red hepatization
-characterized by massive confluent exudation w/red cells (congestion), neutrophils, and fibrin filling the alveolar spaces.

3. Gray hepatization
-characterized by progressive disintegration of red cells and the persistence of a fibrinosuppurative exudate.

4. Resolution
-the consolidated exudate within the alveolar spaces undergoes progressive enzymatic digestion to produce a granular, semifluid, debris that is resorbed, ingested by macrophages, coughed up, or organized by fibroblasts growing into it.
134. What are 4 complication of lobar pneumonia or bronchopneumonia?
1. Abscess formation
2. Empyema (spread of infection to pleural cavity)
3. Organization of exudate into fibrotic scar tissue
4. Bacteremia and sepsis, with infection of other organs
135. On radiograph, how can one tell the difference btwn brochopneumonia vs. lobar pneumonia?
The characteristic radiologic appearance of lobar pneumonia is that of a radio-opaque, usually well-circumscribed lobe, whereas bronchopneumonia shows focal opacities.
136. What are the community acquired atypical (viral and mycoplasmal) pneumonias?
Infections by viruses or Mycoplasma pneumoniae range from relatively mild URI to severe lower respiratory tract disease.

The term atypical means a moderate amount of sputum, no physical findings of consolidation, only moderate elevation of WBCs and lack of alveolar exudate.

The pneumonitis is most commonly caused by Mycoplasma pneumoniae.
137. What is the common pathogenetic mechanism of the atypical pneumonias?
The common pathogenetic mechanism is attachment of the organisms to the upper respiratory tract epithelium followed by necrosis of the cells and an inflammatory response.

Damage to and denudation of the respiratory epithelium inhibit mucociliary clearance and predispose to secondary bacterial infections.
138. What is the morphology of atypical pneumonias?
Patchy or lobar areas of congestion are seen without the consolidation of bacterial pneumonias. Other findings are:

1. Predominant interstitial pneumonitis w/widened, edematous alveolar walls containing mononuclear inflammatory cell infiltrates may be seen.
2. Hyaline membranes reflect diffuse alveolar damage
4. Frequent, superimposed bacterial infection is seen
5. Certain viruses cause necrosis in sever infections (herpes simplex, adenovirus, varicella); in some, characteristic cytopathic changes occur (e.g. cytomegaly and nuclear inclusions in CMV).
139. Influenza infections
Type A influenzaviruses infect humans and are the major cause of influenza epidemics through viral mutations.

Types B and C do not mutate; consequently, childhood infections result in largely life-long antibody-mediated protection against future disease.
140. What are the two mechanisms that account for the clearance of primary influenza virus infection?
1. Cytotoxic T cells

2. Intracellular anti-influenza protein (called Mx1) is induced in macrophages by the cytokines interferon alpha and beta.
141. What is the morphology of influenza infections?
Viral URIs are marked by mucosal hyperemia and swelling with a predominantly lymphomonocytic and plasmacytic infiltration of the submucosa accompanied by overproduction of mucus secretions.

The swollen mucosa and viscid exudate may plug the nasal channels, sinuses, or the eustachian tubes and lead to secondary bacterial infection.

Virus-induced tonsillitis w/enlargement of the lymphoid tissue within Waldeyer ring is frequent in children.
142. What is the morphology of laryngotracheobronchitis and bronchiolitis?
There are vocal cord swelling and abundant mucous exduation.

Impairment of bronchociliary function invites bacterial superinfection w/more marked suppuration. Plugging of small airways may give rise to focal lung atelectasis.

Can result in obliterative bronchiolitis and permanent lung damage.
143. What is SARS?
SARS first appear in China in 2002.

One third of patients recover; the remainder progress to severe respiratory disease and nearly 10% die.

It is caused by a previously unknown coronavirus, spread mainly through infected respiratory secretions.

The lungs show diffuse alveolar damage and multinucleated giant cells.
144. What is nosocomial pneumonia?
Nosocomial pneumonia is defined as infection acqruired during hospitalization.

These pneumonias occur in patients with severe underlying disease or invasive access devices, and are serious life-threatening complications.
145. What are the most common isolates in nosocomial pneumonia?
Gram negative rods (enterobacteriaceae and Pseudomonas species) and Staphylococcus aureus are the most common isolates.

*Strep pneumoniae is not a major pathogen in nosocomial infections.
146. What is aspiration pneumonia?
Aspiration pneumonia occurs in markedly debilitated or unconscious patients; it results in partly chemical (gastric acid) and partly bacterial (mixed oral flora) pneumonia.

Aerobes are more commonly found than anaerobes.
147. What are lung abscesses?
Lung abscess describes a local suppurative process within the lung, characterized by necrosis of lung tissue.

Commonly involved are staphylococci, stretococci, numerous gram-negative species, and anaerobes.

Mixed infections are frequent, reflecting aspiration of oral contents as a common etiology.
148. How are the causative organisms of lung abscesses introduced?

5 ways...
1. Aspiration of infective material
2. Antecedent primary bacterial infection (S. aureus, Klebsiella pneumonia, and the type 3 pneumococcus)
3. Septic embolism
4. Neoplasia
5. Miscellaneous
149. What is the morphology of abscesses?
They contain variable mixtures of pus and air, depending on avaiable drainage through airways.

Pulmonary abscesses due to aspiration are more common on the right, and are most often single.

Continued infection leads to large, fetid, green-black, multilocular cavities with poor demarcation of their margins, designated gangrene of the lung. CONTINUED
150. What is the cardinal histologic change in all lung abscesses?
*Suppurative destruction of the lung parenchyma within the central area of cavitation.*

In chronic cases, considerable fibroblastic proliferation produces a fibrous wall.
151. What are the clinical manifestations of lung abscesses?
Cough, fever, copious amount of foul-smelling purulent or sanguineous sputum.

Fever, chest pain, and weight loss are common. Clubbing of the fingers and toes may appear within a few weeks after the onset of an abscess.
152. What is chronic pneumonia?
Chronic pneumonia is typically a localized granulomatous inflammation in immunocompetent patients, with or without regional lymph node involvement.

In the immunocompromised, the infection may become disseminated.

Can be caused by bacteria or fungi.
153. What is histoplasmosis?
Histoplasmosis capsulatum infection is acquired by inhalation; it is endemic along the Ohio and Mississippi rivers and in the Caribbean.

Heat shock protein expressed by the fungus binds to the surface of macrophages, which stimulates interferon and TNF which kills the fungus.

Lacking cellular immunity, patients with AIDS are susceptible to disseminated infections with Histoplasma, which is a major opportunistic pathogen in this disease.
154. Morphology of histoplasmosis
Infection produces granulomas with coagulative necrosis and coalesce to produce large areas of consildation but may also liquefy to form cavities.

With sponaneous or drug control of the infection, these lesions subsequently undergo fibrosis and concentric calcification *(tree bark appearance).

Silver stain identifies the 3-5 um thin walled cyst of the fungus, which can persist for years.
155. Chronic histoplasmosis
Gray-white granulomas are usually present in the apices of the lungs with retraction and thickening of the pleura and in the hilar nodes.

Further progression involves more and more of the lung parenchyma, with cavity formation less frequent than in tuberculosis.
156. Fulminant disseminated histoplasmosis
Occurs in immunosuppressed individuals. Epithelioid cell granulomas are not formed; instead, there are focal accumulations of mononuclear phagocytes filled w/fungal yeasts throughout the tissues and organs of the body.

The presence of macrophages stuffed with organisms resembles that found in severe cases of visceral leishmaniasis.
157. What are the clinical presentations of histoplasmosis?

4 items...
1. A self-limited and often latent primary pulmonary involvement, which may result in coin lesions on chest radiography
2. Chronic, progressive, secondary lung disease, which is localized to the lung apices and causes cough, fever, and night sweats.
3. Localized lesions in extrapulmonary sites, including mediastinum, adrenal, liver, or meninges
4. A widely disseminated involvement, particularly in immunosuppressed patients.
158. What is blastomycosis?

What are the three clinical forms?
Blastomyces dermatidis is a soil-inhabiting, dimorphic fungus that is difficult to isolate.

It occurs in the central and southeastern US, Canada, Mexico, the Middle east, Africa, and India.

Three clinical forms:
1. Pulmonary blastomycosis
2. Disseminated blastomycosis
3. Rare primary cutaneous form that results from direct inoculation of organisms into the skin
159. What is the clinical presentation of blastomycosis?
Pulmonary bastomycosis most often presents as an abrupt illness w/productive cough, headache, chest pain, weight loss, fever, abdominal pain, night sweats, chills, and anorexia.

Chest radiographs reveal lobar consolidation, multilobar infiltrates, perihilar infiltrates, multiple nodules, or miliary infiltrates.

The upper lobes are most frequently involved.
160. What is the morphology of bastomycosis?
In the normal host, the lung lesions of blastomycosis are suppurative granulomas.

Macrophages have a limited ability to ingest and kill B. dermatidis, and the persistence of the yeast cells leads to continued recruitment of neutrophils.

In tissue, B. dermatidis is a round, 5- to 15um yeast cell that divides by broad-based budding. It has a thick, double-contoured cell wall and multiple nuclei.

When in cutaneous form, it can be mistaken for squamous cell CA.
161. What is coccidioidomycosis?
Coccidioidomycosis is endemic to areas of the Southwest and western US and Mexico.

Coccidioides immitis causes lesions varying from pyogenic to granulomatous; silver stains demonstrate a 20-60 um thick walled spherule containing small endospores.
162. What are the common causes of pneumonia in the immunocompromised host?
1. Bacteria (Pseudomonas aeruginosa, Mycobacterium species, Leionella pneumophilia, and Listeria monocytogenes)

2. Viruses (CMV and herpes virus)

3. Fungi (Pneumocystic carinii, Candida species, Aspergillus species, the Phycomycetes, and Cryptococcus neoformans)
163. What are the pulmonary diseases associated in patients with AIDS?
In theses patients pulmonary disease may be due to more than one cause and symptoms may be atypical.

The CD4+ T-cell count can define the risk of infection w/specific organisms.

In addition to opportunistic infections, the usual bacterial pathogens cause severe disease

Malignancies (Kaposi sarcoma, lymphoma, lung CA) also cause pulmonary disease
164. CD4+ T cell count three rules of thumb...
1. Bacterial and tubercular infections are more likely at higher CD4+ counts (> 200 cells/mm^3)

2. Pneumocystic pneumonia usually strikes at CD4+ counts below 200 cells/mm^3

3. CMV and Mycobacterium avium complex infections are uncommon until the very late stages of immunosuppression (<50cells/mm^3)
165. Pulmonary infections in lung transplantations
They are essentially those of any immunocompromised host.

They include bacterial and viral (especially CMV), penumonias, Pneumocystic carinii, and fungal infections.

In the early posttransplant period, bacterial infections are most common.
166. When do most pulmonary infections in lung transplantations occur?
Most cases occur in the months 3-12 after transplant.
167. Morphology of acute rejection of transplanted lung
The morphologic features of acute rejection are those of inflammatory infiltrates (lymphocytes, plasma cells, and few neutrophils and eosinophils), either around small vessels, in the submucosa of airways, or both.
168. Chronic rejection of transplanted lung

What is the major morphological correlate of chronic rejection?
Chronic region is a significant problem in at least half of all lung transplant patients by 3-5 years.

The major morphological correlate of chronic rejection is bronchiolitis obliterans, the partial or complete occlusion of small airways by fibrosis, with or w/o active inflammation.

Bronchiolitis obliterans is patchy and therefore difficult to Dx via transbronchial biopsy.
169. Lung cancer prevalence and prognosis
Lung CA occurs most often between ages 40 & 70, w/a peak incidence in the 50's or 60's. Only 2% of all cases appear before 40.

The outlook for patients diagnosed w/lung CA is dismal. The 1-year survival rate has increased from 34% in '75 to 41% in '97, largely owing to improvements in surgical techniques. However, the 5-year survival rate for all stages combined is only 15%.
170. What is the statistical evidence linking smoking w/lung CA?
87% of lung CA occur in active smokers or those who have stopped recently.

There was an association between the freq of lung CA and:
1. amt of daily smoking
2. tendency to inhale
3. duration of smoking habit

Compared w/non-smokers, avg smokers have a 10x higher risk of developing lung Ca and heavy smokers have a 60x higher risk.

Women have a higher susceptibility to tobacco carcinogens than men do.
171. Cigarette smoking is also linked with what other types of cancers?
Mouth, pharynx, larynx, esophagus, pancreas, uterine cervix, kidney, and urinary bladder CAs.
172. Secondhand smoke
Contains numerous human carcinomgens for which there is no safe level of exposure.

Each year, about 3,000 non-smokers die of lung CA as a result of breathing secondhand-smoke.
173. Clinical evidence of tobacco and lung CA link
Obtained though observations of histologic changes in the lining epithelium of the respiratory tract in habitual smokers.

In essence, there is a linear correlation between the intensity of exposure to cigarette smoke and the appearance of ever more worrisome epithelial changes that begin w/squamous metaplasia and progress to squamous dysplasia, carcinoma in situ, and invasive carcinoma.
174. What 3 industrial/environmental hazards are linked w/lung CA?
1. High dose ionizing radiation
2. Asbestos
3. Radon gas
175. What are the two clinical subgroups of lung CAs?
1. Small cell carcinoma
2. Non-small cell carcinoma
176. What are the four dominant oncogenes that are frequently involved in lung CA?
1. c-MYC
2. K-RAS
3. EGFR
4. HER-2/neu
177. What are the four commonly deleted or inactivated tumor suppressor genes that are freq involved in lung CA?
1. p53
2. RB
3. p16^(INK4a)
4. multiple loci on chromosome 3p
178. What is at chromosome 3p?
At this locale, there are numerous candidate tumor suppressor genes, such as FHIT, RASSF1A, and other that remain to be identified.
179. Of all the genetic alterations associated w/lung CA, which mutations are common to both small cell and non-small cell lung CA?
p53 mutations
180. Small cell CAs vs. non-small cell CAs genetic alterations
Small cell CAs harbor more frequent alterations in c-MYC and RB

Non-small cell tumors are associated w/mutations in RAS and p16^(INK4a).
181. CYP1A1 alleles
People w/certain alleles of CYP1A1 have an increased capacity to metabolize procarcinogens derived from cigarette smoke and, conceivably, incur the greatest risk of developing lung CA.

Similarly, individuals whose peripheral blood lymphocytes undergo chromosomal breakages following exposure to tobacco-related carcinogens have a greater than 10x risk of developing lung CA.
182. What are the 3 types of precursor epithelial lesions recognized in lung CA?
1. Squamous dysplasia and carcinoma in situ
2. Atypical adenomatous hyperplasia
3. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

*Currently, it is not possible to distinguish between preinvasive lesions that are likely to progress and those that will remain localized.
183. What are the 4 major categories of lung CAs?
1. Squamous cell carcinoma
2. Adenocarcinoma
3. Small cell carcinoma
4. Large cell carcinoma
184. Adenocarcinoma is the most common form of lung CA in what gender?

Why?
Women, and in many studies, men as well;

A possible explanation is that changes in cigarette type have caused smokers to inhale more deeply and thereby expose more peripheral airways and cells (with a predilection to adenocarcinoma) to carcinogens.
185. Small cell CAs vs. non-small cell CAs metastasis and chemosensitivity
Small cell CAs - most often metastatic, high initial response to chemotherapy

Non-small cell CAs - less often metastatic, less responsive to chemotherapy

The strongest relationship to smoking is with squamous cell and small cell CA.
186. Where do lung CAs most often arise?
In and about the hilus of the lung. About 3/4 of the lesions take their origin from first order, second order, and third order bronchi.

A small number of primary CAs of the lung arise in the periphery of the lung substance from the alveolar cells or terminal bronchioles. These are predominantly adenocarcinomas, including those of the bronchioloalveolar type.
187. Squamous cell lung CA progression
Squamous cell CA of the lung begins as an area of in situ cytologic dysplasia that over an unknown interval of time, yields a small area of thickening or piling up of bronchial mucosa.

With progression, this small focus, usually less than 1 cm^2 assumes that appearance of an irregular, warty excrescence that elevates or erodes the lining epithelium.

The tumor may then follow of variety of paths, into the bronchial lumen, bronchus, adjacent region of the carina or mediastinum, etc...
188. Morphology of lung CAs
In almost all patterns, the neoplastic tissue is gray-white and firm to hard.

Especially when the tumors are bulky, focal areas of hemorrhage or necrosis may appear to produce yellow-white mottling and softening.

Sometimes these necrotic foci cavitate. Often these tumors erode the bronchial epithelium and can be diagnosed by cytologic exam of sputum, bronchoalveolar lavage fluid, or fine needle biopsy.
189. How do lung CA metastases spread?
Spread through both lymphatic and hematogenous pathways.

These tumors have a disturbing habit of spreading widely throughout the body and at an early stage in their evolution except for squamous cell CA, which metastasizes outside the thorax late.

Often the metastasis presents are the first manifestation of the underlying occult pulmonary lesion.
190. Where do the lung metastases most commonly spread?
No other organ or tissue is spared, but the *adrenals* for obscure reasons are involved in more that 50% of cases.

The liver (30-50%), brain (20%) and bone (20%) are additional favored sites of metastases.
191. Morphology of squamous cell carcinoma
Squamous cell CA is most commonly found in men and is closely correlated w/a smoking history.

*Histologically, this tumor is characterized by the presence of keratinization and/or intercellular bridges.*

Keratinization may take the form of squamous pearls or individual cells w/markedly eosinophilic dense cytoplasm. Squamous metaplasia, epithelial dysplasia, and foci of frank carcinoma in situ may be seen in bronchial epithelium adjacent to the tumor mass.

Microscopically, they vary from well differentiated ketatinizing neoplasms to anaplastic tumors w/only focal squamous differentiation.

Mitotic activity is higher in poorly differentiated tumors.
192. 5 genetic alterations in squamous cell carcinomas

Which is most common?
1. Squamous cell carcinomas show the highest frequency of p53 mutations of all histologic types of lung CA. p53 protein overexpression and less commonly, mutations may precede invasion. There is an increasing freq and intensity of p53 immunostaining w/higher-grade dysplasia.

2. Loss of protein expression of the tumor suppressor gene RB is detected in 15% of cases.

3. The CDK-inhibitor p16^(INK4a) is inactivated, and its protein product is lost in 65% of tumors.

4. Overexpression of epidermal growth factor receptor has been detected in 80% of cases, but is is rarely mutated

5. HER-2/neu is highly expressed in 30% of these cancers, but unlike in breast CA, gene amplification is not the underlying mechanism.
193. Morphology of adenocarcinomas
This is a malignant epithelial tumor w/glandular differentiation or mucin production by the tumor cells.

Adenocarcinomas show various growth patterns, sometimes mixed, including acinar, papillary, bronchioloalveolar, and solid w/mucin formation. Of these, only the pure bronchioloalveolar carcinoma has distinct gross, microscopic and clinical features.
194. Prevalence of adenocarcinomas
Most common type of lung CA in women and nonsmokers.
195. Locations and composition of adenocarcinomas
As compared to squamous cell CAs, the lesions are usually more peripherally located, and tend to be smaller.

They vary histologically from well-differentiated tumors w/obvious glandular elements to papillary lesions resembling other papillary carcinomas to solid masses w/only occasional mucin producing glands and cells. About 80% contain mucin.

Adenocarcinomas grow more slowly than squamous cell CAs but tend to metastasize widely and earlier.
196. What genetic alterations are seen primarily in lung adenocarcinomas?
K-RAS mutations are seen primarily in adenocarcinoma, w/a much lower freq in nonsmokers (5%) than in smokers (30%).

p53, RB, and p16 mutations and inactivation have the same frequency in adenocarcinoma as in squamous cell carcinoma.
197. Morphology of bronchioloalveolar carcinoma
Bronchioloalveolar carcinoma is the most uncommon form of adenocarcinoma arising in the terminal bronchioloalveolar regions.

Grossly, there may be single or multiple nodules or a diffuse, pneumonia-like tumor consolidation.

***Histologically, the tumor is characterized by a pure bronchioloalveolar growth pattern w/no evidence of stromal, vascular, or pleural invasion. There are distinctive, tall, columnar, often mucin producing tumor cells arrayed along preserved alveolar septa, and forming papillary projections.***
198. What is the key feature of bronchioloalveolar carcinomas?
Their growth along pre-existing structures w/o destruction of alveolar architecture.

This growth pattern has been termed "lepidic", an allusion to the neoplastic cells resembling butterflies sitting on a fence.
199. What are the two subtypes of bronchioloalveolar carcinoma?

What are the features and distinctions of each type?
1. Nonmucinous
-has columnar, peg-shaped, or cuboidal cells
- often consist of a peripheral lung nodule w/only rare aerogenous spread and therefore are amenable to surgical resection.

2. Mucinous
-has distinctive, tall, columnar cells w/cytopalsmic and intra-alveolar mucin, growing along the alveolar septa.
-tend to spread aerogenously,forming satellite tumors. These may be present as a solitary nodule or as multiple nodules, or an entire lobe may be consolidated by tumor resembling lobar pneumonia. Less likely to be cured by surgery.
200. What is the proposed sequence of progression in the formation of adenocarcinomas?
Adenocarcinoma of the lung arises from atypical adenomatous hyperplasia progressing to bronchioloalveolar carcinoma, which then transforms into invasive adenocarcinoma.

This is supported by the fact that lesions of atypical adenomatous hyperplasia are monoclonal and they share many molecular aberrations w/invasive adenocarcinomas.
201. What is the morphology of atypical adenomatous hyperplasia?
Microscopically, it is recognized as a well-demarcated focus of epithelial proliferation composed of cuboidal to low columnar epithelium.

These cells demonstrate some cytologic atypia but not to the extent seen in frank adenocarcinoma.
202. Morphology of small call carcinoma
This highly malignant tumor has as distinctive cell type. ***The epithelial cells are small, w/scant cytoplasm, ill defined cell borders, finely granular nuclear chromatin (salt and pepper pattern) and absent or inconspicuous nucleoli.***

The cells are round, oval, and spindle shaped, and nuclear molding is prominent. The mitotic count is high. The cells grow in clusters that exhibit neither glandular nor squamous organization. Necrosis is common and often extensive.

Basophilic staining of vascular wall due to encrustation by DNA from necrotic tumor cells is freq present.
203. Combined small cell carcinoma
A single variant of small cell CA; there is a mixture of small cell carcinoma and any other non-small cell component, including large cell neuroendocrine carcinoma and sarcoma.
204. Where do small cell carcinomas originate from?
The occurrence of neurosecretory granules, the ability of some of these tumors to secrete polypeptide hormones, and the presence of neuroendocrine markers such as chromogranin, synaptophysin, and Leu-7 (in 75% of cases) and PTH-like and other hormonally active products suggest derivation of this tumor from neuroendocrine progenitor cells of the lining bronchial epithelium.

They are the most common pattern associated w/ectopic hormone production.
205. Small cell carcinoma features
Small cell carcinomas have a strong relationship to cigarette smoking. They occur both in major bronchi and in the periphery of the lung.

There is no known perinvasive phase or carcinoma in situ.

They are the most aggressive of lung tumors, metastasize widely, and are virtually incurable by surgical means.
206. What genetic alterations are most commonly associated w/small cell carcinoma?
p53 and RB tumor suppressor genes are frequently mutated.

There is also intense expression of the anti-apoptotic gene BCL2 in 90% of tumors, in contrast w/a low frequency of expression of the pro-apoptotic gene BAX.
207. Morphology of large cell carcinomas
This is an undifferentiated malignant epithelial tumor that lacks the cytologic features of small cell carcinoma and glandular or squamous differentiation.

***The cells typically have large nuclei, prominent nucleoli, and a moderate amount of cytoplasm.***

Large cell carcinomas probably represent squamous cell carcinomas and adenocarcinomas that are so undifferentiated that they can no longer be recognized by light microscopy.

Ultrastructurally, however, minimal glandular or squamous differentiation is common.
208. Morphology of large cell neuroendocrine carcinoma
*This is a histologic variant of large cell carcinomas; this is recognized by such features as organoid nesting, trabecular, rosette-like and palisading patterns.*

These features suggest neuroendocrine differentiation; this tumor has the same molecular changes as small cell carcinoma.
209. Secondary pathology associated w/lung CA
Lung CAs cause related anatomic changes in the lung substance distal to the point of bronchial involvement.

**Partial obstruction may cause marked focal emphysema; total obstruction may lead to atelectasis.

The impaired drainage of the airways is a common cause for severe suppurative or ulcerative bronchitis or bronchiectasis.

Pulmonary abscesses sometimes call attention to a silent carcinoma that has initiated the chronic suppuration.

Extension to the pericardial or pleural sacs may cause pericarditis or pleuritis w/significant effusions.
210. What is superior vena cava syndrome?
Compression or invasion of the SVC can cause venous congestion, dusky head and arm edema, and ultimately circulatory compromise.
211. T1 - T2 staging
T1: Tumor <3cm w/o pleural or main stem bronchus involvement

T2: Tumor >3cm or involvement of main stem bronchus 2 cm from carina, visceral pleural involvement or lobar atelectasis
212. T3 - T4 staging
T3: Tumor w/involvement of chest wall, diaphragm, mediastinal pleura, pericardium, main stem bronchus 2 cm from carina, or entire lung atelectasis

T4: Tumor w/invasion of mediastinum, heart, great vessels, trachea, esophagus, vertebral body, or carina or with a malignant pleural effusion
213. N0 - N3 staging
N0: No demonstrable metastasis to regional lymph nodes

N1: Ipsilateral hilar or peribronchial nodal involvement

N2: Metastasis to ipsilateral mediastinal or subcarinal lymph nodes

N3: Metastasis to contralateral mediastinal or hilar lymph nodes, ipsilateral or contralateral scalene, or supraclavicular lymph nodes
214. M0 - M1 staging
M0 - no known distant metastasis

M1 - distant metastasis present
215. Clinical features of lung CA
Lung CA usually present w/cough, weight loss, chest pain, and dyspnea.

Outcome depends on stage at presentation. Overall 5-year survival rate is 15%; surgical resection of solitary (non-small cell) tumors (a minority of patients) has better survival rate (48%).

Small cell carcinoma has almost always metastasized by the time of Dx, precluding surgical intervention. It is response to chemotherapy but ultimately recurs.
216. What are paraneoplastic syndromes?
Lung CA can be associated w/a number of paraneoplastic syndromes, some of which may antedate the development of a gross pulmonary lesion.
217. What are the hormones or hormone-like factors do paraneoplastic syndromes elaborate?
1. ADH, inducing hyponatremia owing to inappropriate ADH secretion
2. ACTH, producing Cushing syndrome
3. PTH, PTH-related peptide, Prostaglandin E, and some cytockines, all implicated in the hypercalcemia often seen w/lung CA
4. Calcitonin, causing hypocalcemia
5. Gonadotropins, causing gynocomastia
6. Serotonin and bradykinin, associated w/the carcinoid syndrome.
218. Which hormones are most commonly secreted in small cell CAs?

Squamous cell CAs?
ACTH and ADH are prdeominantly produced by small cell carcinomas

Tumors that produce hypercalcemia are mostly squamous cell carcinomas.

Carcinoid syndrome is more common w/the carcinoid tumor, but small cell carcinoma occurs much more commonly.
219. What are some other systemic manifestations of lung carcinoma?
1. Lambert-Eaton myasthenic syndrome
-muscle weakness is caused by auto-antibodies directed to the neuronal calcium channel

2. Peripheral neuropathy, usually purely sensory

3. Dermatologic abnormalities, such as acanthosis nigrican

4. Hematologic abnormalities, such as leukemoid reactions

5. Hypertrophic pulmonary osteoarthropathy, a connective tissue disorder associated w/clubbing of the fingers

6. Horner syndrome, from pancoast tumors.
220. How do neuroendocrine lesions relate to the neuroendocrine system?
They share morphologic and biochemical features, but are classified differently since there are significant differences between them.

The normal lung contains neuroendocrine cells within the epithelium as single cells or as clusters, the neuroepithelial bodies. Neoplasms of neuroendocrine cells in the lung include benign tumorlets, carcinoids, and the large and small cell carcinoma of the lung.
221. MEN type 1
Both typical and atypical carcinoids can occur in patients w/multiple endocrine neoplasia type I
222. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
While virtually all pulmonary neuroendocrine cell hyperplasias are secondary to airway fibrosis and/or inflammation, a rare disorder called diffuse idiopathic pulmonary neuroendocrine cell hyperplasia appears to be a precursor to the development of multiple tumorlets and typical or atypical carcinoids.
223. Carcinoid tumors
These are low-grade malignant epithelial neoplasms that are subclassified into typical and atypical carcinoids.

They represent 1-5% of all lung tumors and have neuroendocrine differentiation.
224. Typical vs. atypical carcinoids in genetic alterations
Typical carcinoids have no p53 mutations or BCL2/BAX imbalance, while atypical carcinoids show these changes in 20-40% and 10-20% of tumors, respectively.

Some carcinoids also show LOH at 3p, 13q14 (RB), 9p, and 5q22, which are found in all neuroendocrine tumors w/increasing frequency from typical to atypical carcinoid to large cell neuroendocrine and small cell carcinoma.
225. Morphology of carcinoids
May arise centrally or may be peripheral. Grossly, the tumors are usually intrabronchial, highly vascular, polypoid masses less than 3-4 cm. (Collar button lesions).

Microscopically, there are nests and cords of uniform, small round cell resembling intestinal carcinoids.

*Histologically, the tumor is composed of organoid, trabecular, palisading, ribbon, or rosette-like arrangements of cells separated by a delicate fibrovascular stroma.*
226. How to differentiate between typical and atypical carcinoids?
Typical carcinoids have < 2 mitoses per 10 high power fields and lack necrosis.

Atypical carcinoids have between 2-10 mitoses per 10 high power fields, and/or foci of necrosis. They also tend to show more cellular atypica, increased cellularity, nucleoli, lymphatic invasion, and disorganized architecture. Spread to local lymph nodes at time of resection is more likely w/atypical carcinoids.
227. What is the classic carcinoid syndrome?
Classic carcinoid syndrome is characterized by intermittent attacks of diarrhea, flushing, and cyanosis.
228. Hamartomas
Hamartomas are relatively common, benign, nodular neoplasms composed of cartilage and other mesenchymal tissues (e.g. fat, blood vessels, fibrous tissue). Cartilage is the most common connective tissue.
229. Inflammatory myofibroblastic tumor
Rare, but more common in children.*

Presenting symptoms include fever, cough, chest pain, and hemoptysis. Can also be asymptomatic. Imaging reveals a single round, well-defined usually peripheral mass w/calcium deposits in about a quarter of cases.

Grossly, the lesion is firm, 3-10 cm in diameter, and grayish white.

*Microscopically there is proliferation of spindle shaped fibroblasts and myofibroblasts, lymphocytes, plasma cells, and peripheral fibrosis.*

They are neoplastic proliferations.
230. Tumors in the mediastinum
Can arise in mediastinal structures or may be metastatic form the lungs or other organs.

They may also invade or compress the lungs.
231.Morphology of metastatic tumors
Secondary involvement of the lung by metastatic tumors is common can can occur via direct extension from contiguous organs, or lymphatics or hematogenous routes.

Patters of disease include discrete mass or nodules, growth withing peribronchial lymphatics (lymphangitis carcinomatosa), and rarely multiple tumor emboli.

*Look for cannonball lesions
232. What is pleural effusion?
Pleural effusion is a common manifestation of both primary and secondary pleural diseases. Normally, no more than 15 mL of serous, relatively acellular, clear fluid lubricates the pleural surfaces.

The increased accumulation of pleural fluid is called pleural effusion.
233. Increased pleural effusion occurs in what 5 settings?
1. Increased hydrostatic pressures, as in CHF
2. Increased vascular permeability, as in pneumonia
3. Decreased osmotic pressure, as in nephrotic syndrome
4. Increased intraplaural negative pressures, as in atelectasis
5. Decreased lymphatic drainage, as in mediastinal carcinomatosis
234. What is serous, serofibrinous and fibrinous pleuritis?

Which comes first?
These are caused by the same processes.

Fibrinous exudations generally reflect a later, more severe exudative reaction that, in an earlier developmental phase, might have presented as a serous or serofibrinous exduate.
235. What does serofibrinous pleuritis reflect?
Serofibrinous pleuritis reflects pulmonary inflammation (e.g., tuberculosis, pneumonia, infarcts, abscesses, or systemic diseases such as RA, uremia).
236. What does suppurative pleuritis or empyema usually reflect?
A purulent pleural exudate (empyema) usually results from bacterial or mycotic seeding of the pleural space.

Most commonly, this seeding occurs by contiguous spread of organisms from intrapulmonary infection, but occasionally, it occurs thru lymphatic or hematogeneous routes from a more distant source.
237.What is empyema characterized by?
Empyema is characterized by loculated, yellow-green, creamy pus composed of masses of neutrophils admixed with other leukocytes.

Although it may accumulate in large volumes (up to 500-1000 mL), usually the volume is small, and the pus becomes localized.
238. What is hemorrhagic pleuritis?
True hemorrhagic pleuritis manifested by sanguineous inflammatory exudates is infrequent and is found in hemorrhagic diatheses, rickettsial disease, and neoplastic involvement of the pleural cavity.

When it is encountered, careful search should be made for the presence of exfoliated tumor cells.
239. What are other noninflammatory pleural effusions?
Other pleural fluid accumulations include hemothorax (a fatal complication of a ruptured aortic aneurysm) and chlyothorax (a collection of milky lymph fluid, usually w/neoplastic lymphatic obstruction).

True chlye should be differentiated from turbid serious fuid, which does not contain fat and does not separate into an overlying layer of high fat content. Chlyothorax may be bilateral but is more often confined to the left side.
240. What is pneumothorax most commonly associated with?
***Pneumothorax is most commonly associated with emphysema, asthma, and tuberculosis.***

Pneumothorax can be traumatic (e.g., after rib fractures that puncture the lung) or spontaneous, occurring after peripheral apical bleb rupture.
241.Of the various forms of pneumothorax, what is the one that attracts greatest clinical attention?
The so-called spontaneous idiopathic pneumothorax.

This entity is encountered in relatively young people; appears to be due to rupture of small, peripheral, usually apical subpleural blebs; and usually subsides spontaneously as the air is resorbed. Recurrent attacks are common and ca be quite disabling.
242. What is tension pneumothorax?
Occasionally, the lung collapse is marked. When the defect acts as a flap valve and permits the entrance of air during inspiration, but fails to permit its escape during expiration, it effectively acts as a pump that creates the progressively increasing pressures of tension pneumothorax, which may be sufficient to compress the vital mediastinal structures and the contralateral lung.
243. What are the most frequent metastatic malignancies that arise in the pleura?
The most frequent metastatic malignancies arise from primary neoplasms of the lung and breast.

Ovarian carcinomas, for example, tend to cause widespread implants in both the abdominal and thoracic cavities.
244. What are solitary (localized) fibrous tumors?
Previous called "benign mesothelioma", localized fibrous tumors are now recognized as soft tissue tumors w/a propensity to occur in the pleura and less commonly, in the lung, as well as other sites.

The tumor is often attached to the pleural surface by a pedicle. It may be small or may reach an enormous size, but it tends to remain confined to the surface of the lung.
245. What is the morphology of solitary localized fibrous tumors?
Grossly, they consist of dense fibrous tissue with occasional cysts filled with viscid fluid; microscopically, the tumors show whorls of reticulin and collagen fibers among which are interspersed spindle cells resembling fibroblasts.

The tumors cells are CD34+ and ketatin-negative by immunostaining. This feature can be diagnostically useful in distinguishing these lesions from malignant mesotheliomas (which show the opposite phenotype).
246. What is malignant mesothelioma?
This uncommon tumor of mesothelial cells occurs most often in the pleura (less freq in the peritoneum or other sites).

It is associated with occupational exposure to asbestos in 90% of cases; only 20% of these pts have pulmonary asbestosis. The lifetime risk (not affected by smoking) in heavily exposed individuals is 7-10%, with a latency period between exposure and tumor development of 25-45 years.

**This is in contrast to the risk of asbestos-related lung CA, already high, and is markedly magnified by smoking. Thus, for asbestos workers (particularly those who are also smokers), the risk of dying of lung CA far exceeds that of developing mesothelioma.
247. What are the genetic mutations linked to mesothelioma?
Studies have shown that approx 60-80% of malignant mesotheliomas have deletions in chromosomes 1p, 3p, 6q, 9p, or 22q. There is a low frequency of p53 mutations, although p53 accumulation can be detected in 70% of malignant mesotheliomas.

Also, some studies have found the presence of SV40 (simian virus 40) viral DNA sequences in 60-80% of malignant pleural mesotheliomas. The SV40 T-antigen is a potent carcinogen that binds to an inactivates several critical regulators of growth, such as p53 and RB.
248. What is the morphology of malignant mesothelioma?
Malignant mesothelioma is a diffuse lesion that spreads widely in the pleural space and is usually associated w/extensive pleural effusion and direct invasion of the thoracic structures. The affected lung gets ensheathed by a thick layer of soft, gelatinous, grayish pink tumor tissue.

Malignant mesotheliomas consist of a mixture of two cell types: epithelioid types and sarcomatoid type (there is also a mixed type).
249. What is the morphology of the epithelioid type of mesothelioma?
The epithelioid type consists of cuboidal, columnar, or flattened cells forming tubular or papillary structures resembling adenocarcinoma.

These can be difficult to differentiate grossly and histologically from pulmonary adenocarcinomas.
250. What are 5 features one can use to differentiate epithelioid types of mesothelioma from adenocarcinomcas?
Epithelioid types of mesothelioma have:

1. Positive staining for acid mucopolysaccharide
2. Lack of staining for CEA
3. Strong staining for keratin proteins
4. Positive staining for calretinin, Wilms tumor 1 gene product, cytokeratin 5/6, mesothelin, and thrombomodulin
5. On EM, the present of long microvilli and abundant tonofilaments but absent microvillous rootlets and lamellar bodies.**

**Gold standard of Dx is EM
251. What is the sarcomatoid type of mesothelioma?
The mesenchymal type of mesothelioma appears as a spindle cell sarcoma, resembling fibrosarcoma.
252. What are the clinical features of malignant mesothelioma?
Pts present with chest apin, dyspnea, and recurrent pleural effusion. Mesotheliomas are highly malignant tumors that invade the lung and can metastasize widely. Few pts survive longer than 2 years.
253. Where else do mesotheliomas arise?
They also arise in the peritoneum, pericardium, tunica vaginalis, and genital tract.

*Peritoneal mesotheliomas are particularly related to heavy asbestos exposure; 50% of such pts also have pulmonary fibrosis.